DB01242

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2004
gptkbp:approvedBy gptkb:FDA
gptkb:EMA
gptkb:Health_Canada
gptkbp:ATCCode gptkb:N06AX21
gptkbp:bioavailability 50%
gptkbp:brand gptkb:Cymbalta
gptkb:Drizalma_Sprinkle
Irenka
gptkbp:CASNumber gptkb:136434-34-9
gptkbp:category benzodiazepine
antidepressant
norepinephrine reuptake inhibitor
gptkbp:contraindication uncontrolled narrow-angle glaucoma
concurrent use with MAOIs
gptkbp:drugInteraction gptkb:MAO_inhibitors
CYP2D6 inhibitors
CYP1A2 inhibitors
gptkbp:eliminationHalfLife 12 hours
gptkbp:excretion urine
gptkbp:genericAvailable yes
gptkbp:hasInChIKey PTFQOBMPAATQMB-UHFFFAOYSA-N
gptkbp:hasMolecularFormula gptkb:C18H19NOS
gptkbp:hasPatentExpiry 2013 (US)
gptkbp:hasSMILES CN(C)CCOC1=CC=CC=C1C2=CC=CC=C2S
gptkbp:hasUNII O5TNM5N07U
https://www.w3.org/2000/01/rdf-schema#label DB01242
gptkbp:indication gptkb:generalized_anxiety_disorder
gptkb:major_depressive_disorder
fibromyalgia
chronic musculoskeletal pain
diabetic peripheral neuropathic pain
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction serotonin and norepinephrine reuptake inhibitor
gptkbp:metabolism hepatic (CYP1A2, CYP2D6)
gptkbp:molecularWeight 297.42
gptkbp:name gptkb:Duloxetine
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 95%
gptkbp:PubChem_CID gptkb:DB01242
60835
CHEMBL117
D07861
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
constipation
dry mouth
somnolence
decreased appetite
hyperhidrosis
gptkbp:target SLC6A2 (norepinephrine transporter)
SLC6A4 (serotonin transporter)
gptkbp:bfsParent gptkb:Clomipramine
gptkb:clomipramine
gptkbp:bfsLayer 7